Cubist Systematic Strategies, LLC Ascendis Pharma A/S Transaction History

Cubist Systematic Strategies, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$123.45 - $159.4 $1.82 Million - $2.35 Million	14,770 Added 78.19%	33,661 $5.09 Million
Q4 2023 Feb 14, 2024	BUY	$86.1 - $127.36 $1.63 Million - $2.41 Million	18,891 New	18,891 $2.38 Million
Q4 2022 Feb 14, 2023	SELL	$99.42 - $131.97 $250,637 - $332,696	-2,521 Reduced 20.79%	9,603 $1.17 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $800,469 - $1.05 Million	9,526 Added 366.67%	12,124 $1.25 Million
Q2 2022 Aug 15, 2022	BUY	$78.08 - $117.61 $202,851 - $305,550	2,598 New	2,598 $242,000
Q1 2022 May 16, 2022	SELL	$102.18 - $135.75 $11,239 - $14,932	-110 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$127.1 - $169.66 $3,558 - $4,750	-28 Reduced 20.29%	110 $15,000
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $57,236 - $89,875	-508 Reduced 78.64%	138 $22,000
Q2 2021 Aug 16, 2021	BUY	$121.62 - $145.29 $43,175 - $51,577	355 Added 121.99%	646 $85,000
Q1 2021 May 17, 2021	SELL	$124.92 - $173.33 $73,702 - $102,264	-590 Reduced 66.97%	291 $38,000
Q4 2020 Feb 16, 2021	BUY	$151.2 - $182.76 $133,207 - $161,011	881 New	881 $147,000
Q2 2020 Aug 14, 2020	SELL	$110.87 - $156.01 $10,200 - $14,352	-92 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$97.01 - $145.11 $8,924 - $13,350	92 New	92 $10,000
Q2 2019 Aug 14, 2019	SELL	$107.11 - $132.09 $912,255 - $1.13 Million	-8,517 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $248,289 - $519,310	3,995 Added 88.35%	8,517 $1 Million
Q4 2018 Feb 14, 2019	BUY	$55.16 - $69.67 $249,433 - $315,047	4,522 New	4,522 $283,000

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.